ORALIA MARTINEZ: Open Payments
NPI 1730463381 · PHARR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 54 payments from 8 companies in 2025. Trend: 2023 $805 · 2024 $2,594 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $419 |
| Optinose US, Inc. | 7 | $363 |
| Dexcom, Inc. | 12 | $238 |
| Novo Nordisk Inc | 8 | $207 |
| Amgen Inc. | 19 | $160 |
| Lilly USA, LLC | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: AIRSUPRA, Xhance, Dexcom G6 Transmitter, OTEZLA, Wegovy, Ozempic, FARXIGA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
